Medication-Assisted Treatment for Pregnant and Parenting Women
Medication-assisted treatment (MAT) to address substance use disorders has gained increased attention as the rates of prescription drug abuse have steadily grown. Use of MAT with pregnant women with opioid dependencies has complicated relationships between treatment providers, dependency court, and child welfare.
A 2011 webinar, Medication-Assisted Treatment During Pregnancy, Prenatal, and Beyond, covers concrete information about MAT, including dosage, induction, breastfeeding, and the additional use of selective serotonin reuptake inhibitors.
Karol Kaltenbach, Ph.D., also discusses findings from the Maternal Opioid Treatment: Human Experimental Research project. In summary, Cathleen Otero, M.S.W., briefly discusses implications for child welfare.
Technical Assistance Support
The National Center on Substance Abuse and Child Welfare (NCSACW) provides substantial support and expertise to assist sites in strengthening collaboration across systems to improve outcomes for families. Contact NCSACW to learn more.
Substance-Exposed Infants: State Responses to the Problem
Free Online Continuing Education Unit Tutorials
Understanding Child Welfare and the Dependency Court: A Guide for Substance Abuse Treatment Professionals
Understanding Substance Use Disorders, Treatment, and Family Recovery: A Guide for Child Welfare Professionals
Understanding Substance Use Disorders, Treatment, and Family Recovery: A Guide for Legal Professionals
About the NCSACW
The National Center on Substance Abuse and Child Welfare is an initiative of HHS and jointly funded by SAMHSA's Center for Substance Abuse Treatment and the Administration on Children, Youth, and Families, Children's Bureau's Office on Child Abuse and Neglect.
Acta Neuropathologica Communications | Home page
Hace 46 minutos